The Charité is one of the largest university hospitals in Europe. Here, doctors and scientists research, heal and teach at the highest international level. More than half of the German Nobel Prize winners in medicine and physiology come from the Charité, including Emil von Behring, Robert Koch and Paul Ehrlich. Worldwide, the university hospital is highly regarded as an excellent educational institution. Charité – Universitätsmedizin Berlin is the joint medical faculty of the Freie Universität Berlin and the Humboldt-Universität zu Berlin. The Charité is spread over a total of four locations, which includes around 100 clinics and institutes that are bundled into 17 Charité Centers. With 13,200 employees, the Charité generates a total revenue of 1.6 billion euros per year, making it one of Berlin’s largest employers. Including subsidiary companies, the Charité has 17,100 employees. In 2010, the Charité was able to look back on a 300-year long history.
Within the DACE-Project:
The Charité Berlin, in this case the working group “Digital Nephrology” (Prof. Dr. med. Klemens Budde, Dr. med. Fabian Halleck, Dipl. Inf. Danilo Schmidt, Dr. med. Oliver Staeck) from the Medical Clinic with focus on Nephrology and Internal Intensive Care Medicine is the ideal consortium partner for DACE, as the clinic provides optimal application examples. Due to the complexity of their disease, chronically ill patients (in this case patients with chronic kidney disease) in particular require life-long, highly specialized, complex medical care that cannot be provided at the highest level everywhere in Germany.
A close connection to many different doctors and specialists both inside and outside of the hospital, for example in rural residential areas, is necessary. Optimal therapy management requires a cross-sectoral exchange of therapy-relevant information. However, medical expert knowledge is only insufficiently available in these structurally weaker regions and the few local specialists are often overcrowded. Long waiting times for appointments and long distances between the patient’s home and the specialized care center obstruct an optimal therapy result, as quick communication in the event of problems is only inadequately possible.
This results in potentially avoidable complications and preventable hospital stays, which hurt the long-term success of therapy. For this reason, functioning telemedical concepts are regarded as enormously important by all those involved, especially in the care for chronically ill patients in rural areas. Currently, the health policy course for the future is being set, which – among other things – includes the discussion of the expansion of the reimbursement of telemedical treatment. This is why the Berlin Charité as a partner offers the ideal environment to develop DACE and, starting from the pilot test, develop the project further.